Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-13

FDA Approved: PIOGLITAZONE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved a supplemental application for Macleods Pharmaceuticals Limited to market Pioglitazone and Metformin Hydrochloride as a fixed-dose combination …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pioglitazone and Metformin Hydrochloride (Pioglitazone and metformin hydrochloride)

Snippet

SUPPL AP for PIOGLITAZONE AND METFORMIN HYDROCHLORIDE (PIOGLITAZONE AND METFORMIN HYDROCHLORIDE)